We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+2.6%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$3.34B
AUM Growth
+$209M
Cap. Flow
+$157M
Cap. Flow %
4.72%
Top 10 Hldgs %
12.01%
Holding
1,564
New
189
Increased
576
Reduced
529
Closed
163

Sector Composition

Rank Sector Weight
1 Energy 11.94%
2 Healthcare 10.62%
3 Industrials 9.8%
4 Technology 9.43%
5 Financials 9.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
M icon
351
Macy's
M
$6.56B
$2.23M 0.07%
37,696
-1,613
-4% -$89.7K
OAK
352
DELISTED
OAKTREE CAPITAL GROUP, LLC
OAK
$2.22M 0.07%
38,233
-21,712
-36% -$1.27M
TBF icon
353
ProShares Short 20+ Year Treasury ETF
TBF
$87.3M
$2.22M 0.07%
73,160
+2,114
+3% +$66K
VYX icon
354
NCR Voyix
VYX
$1.12B
$2.22M 0.07%
99,050
+56,512
+133% +$1.2M
MUB icon
355
iShares National Muni Bond ETF
MUB
$45.2B
$2.22M 0.07%
20,697
+4,802
+30% +$510K
FDX icon
356
FedEx
FDX
$73B
$2.2M 0.07%
16,608
-114
-0.7% -$15.5K
TRIP icon
357
TripAdvisor
TRIP
$1.65B
$2.18M 0.07%
24,037
-2,330
-9% -$212K
RIG icon
358
Transocean
RIG
$5.62B
$2.18M 0.07%
52,629
+14,654
+39% +$637K
FEX icon
359
First Trust Large Cap Core AlphaDEX Fund
FEX
$1.57B
$2.16M 0.06%
51,316
+16,066
+46% +$659K
MEOH icon
360
Methanex
MEOH
$4.27B
$2.15M 0.06%
33,645
-151
-0.4% -$9.54K
CEM
361
DELISTED
ClearBridge MLP and Midstream Fund Inc.
CEM
$2.15M 0.06%
16,134
+1,093
+7% +$143K
FEN
362
DELISTED
First Trust Energy Income and Growth Fund
FEN
$2.14M 0.06%
65,477
-57
-0.1% -$1.83K
KMB icon
363
Kimberly-Clark
KMB
$36.6B
$2.14M 0.06%
20,216
-50,556
-71% -$5.23M
AWAY
364
DELISTED
HOMEAWAY INC COM
AWAY
$2.14M 0.06%
56,698
+20,753
+58% +$876K
HUM icon
365
Humana
HUM
$44B
$2.13M 0.06%
18,884
+13,562
+255% +$1.41M
PCL
366
DELISTED
PLUM CREEK TIMBER CO (REIT)
PCL
$2.1M 0.06%
49,854
-2,298
-4% -$98.8K
BUD icon
367
AB InBev
BUD
$166B
$2.09M 0.06%
19,840
+2,056
+12% +$209K
POT
368
DELISTED
Potash Corp Of Saskatchewan
POT
$2.08M 0.06%
57,534
-3,863
-6% -$130K
NVDA icon
369
NVIDIA
NVDA
$4.72T
$2.08M 0.06%
4,646,360
-32,200
-0.7% -$13.8K
WPZ
370
DELISTED
WILLIAMS PARTNERS L.P. COM UTS REPTG L.P. INT
WPZ
$2.08M 0.06%
43,285
+3,512
+9% +$165K
GD icon
371
General Dynamics
GD
$103B
$2.07M 0.06%
19,028
+9,689
+104% +$1M
DEM icon
372
WisdomTree Emerging Markets High Dividend Fund
DEM
$3.9B
$2.07M 0.06%
42,201
+571
+1% +$27.1K
PPLI
373
People Inc
PPLI
$3.08B
$2.05M 0.06%
160,359
+35,106
+28% +$451K
XRX icon
374
Xerox
XRX
$456M
$2.04M 0.06%
68,597
+8,826
+15% +$259K
NFG icon
375
National Fuel Gas
NFG
$7.84B
$2.04M 0.06%
29,068
-967
-3% -$70.8K

Similar funds

Oppenheimer & Co's Q1 2014 Portfolio in Review

As of Q1 2014, Oppenheimer & Co held 1,564 positions worth $3.34B, up 6.7% from $3.13B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Oppenheimer & Co deployed $157M of net new capital in Q1 2014, opening 189 new positions and adding to 576 existing holdings. Its largest new stake was Vanguard Morningstar Total Stock Market ETF: 169,083 shares worth $16.5M.

By sector, the portfolio is most concentrated in Energy at 12% of assets, down from 12% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Vanguard Dividend Appreciation ETF, an estimated $7.79M trimmed.

  • Oppenheimer & Co's largest Q1 2014 buy was Vanguard Morningstar Total Stock Market ETF: 169,083 shares worth $16.5M.
  • Oppenheimer & Co added most to Monsanto Co in Q1 2014, an estimated $30M increase.
  • Oppenheimer & Co's biggest Q1 2014 reduction was Vanguard Dividend Appreciation ETF, cutting an estimated $7.79M.
  • Oppenheimer & Co fully exited TetraLogic Pharmaceuticals Corporation in Q1 2014, selling an estimated $10.2M.
  • Oppenheimer & Co's ten largest holdings make up 12% of its $3.34B portfolio in Q1 2014.
  • Oppenheimer & Co opened 189 new positions and closed 163 in Q1 2014.
  • Oppenheimer & Co's portfolio value rose 6.7% quarter-over-quarter to $3.34B.

Based on Oppenheimer & Co's 13F filing for Q1 2014, filed 9 May 2014.